Skip to Main Content

Paper Details

A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.
Addiction
0
2023
HMC, MUD, Women, anxiety, bupropion, men, methamphetamine, methamphetamine use disorder, naltrexone, participants, women
Author NameAffiliation
Philip Todd KorthuisOregon Health and Science University
Steven ShoptawUniversity of California Los Angeles
Steven ShoptawUniversity of California Los Angeles
Steven ShoptawUniversity of California Los Angeles
Steven ShoptawUniversity of California Los Angeles
  • 1 - 5

Datasets

Release 1.2